FURTHER STUDIES OF ANTIGENIC COMPETITION : III. A MODEL TO ACCOUNT FOR THE PHENOMENON BASED ON A DEFICIENCY OF CELL-TO-CELL INTERACTION IN IMMUNE LYMPHOID CELL POPULATIONS by Kerbel, R. S. & Eidinger, David
FURTHER  STUDIES  OF  ANTIGENIC  COMPETITION 
III.  A  MODEL  TO  ACCOUNT FOR THE  PHENOMENON BASED ON A DEFICIENCY 
OF  CELL-TO-CELL  INTERACTION  IN  IMMUNE LYMPHOID 
CELL  POPULATIONS* 
BY  R.  S.  KERBEL  AND  DAVID EIDINGER,  M.D. 
(From the Department  of Microbiology and Immunology,  Queen's University,  Kingston, 
Ontario, Canada) 
(Received for publication 12 December 1970) 
Several experimental observations appear to contradict clonal selection theories of 
humoral antibody formation (1). One of these is antigenic competition, a phenomenon 
whereby  the immune response to  one  antigen can nonspecifically suppress  the  im- 
mune response of a non-cross-reacting antigen administered subsequently (2). 
Considerable controversy has arisen regarding the manner by which the response of 
one clone of cells which is capable of responding to one antigenic specificity, X, can 
affect the response of the second clone of cells which is capable of responding to a 
differing antigenic specificity, Y. Some investigators, on the basis of their experimental 
evidence, have  suggested the  existence of  a  hypothetical, multipotential lymphoid 
cell, occurring with a  limited frequency (3,  4), for which antigens actually compete. 
Such a cell would obviously not be allowed to exist within the theoretical framework 
of clonal-selecfion theories of immunity. Antithetically, if a  mechanism of antigenic 
competition  could  be  found  which  was  compatible with  clonal-selection theories, 
such a finding would greatly strengthen the apparent validity of the theories them- 
selves. Other  authors have interpreted their evidence as compatible with  a  role of 
soluble inhibitory factors released as a  consequence of immunization, to account for 
the nonspecific depression of the immune response to other antigens (5). This would 
imply that the term competition is a misnomer (5). 
A  possible resolution of this problem came with  the  discovery that the immune 
response to many antigens requires the interaction of two separate functionally dis- 
tinct cell types (6,  7):  the  antigen reactive cell which  is thymus-derived (T  cell),  1 
and the antibody-forming cell derived from the bone marrow (B cell). The question 
posed in the present work was whether the immunological deficiency associated with 
antigenic competition was a consequence of interference with the specific interactions 
of T  and B  cells for the second test antigenic specificity arising from immunological 
events induced by the initial suppressing antigen. 
* This work was supported by grants from  the National Cancer Institute, the Ontario 
Heart Foundation, and the Medical Research Council of Canada. 
1  Abbreviations used in this paper: AIS, antigen-induced  suppression; B cell, bone marrow- 
derived cell; GRBC,  goose  erythrocytes; KLH,  keyhole  limpet hemocyanin; RRBC,  rat 
erythrocytes; T cell, thymus-derived cell. 
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The results of  the present work permitted us  to put forth a  new mechanism to 
account for antigenic competition based on  deficiency of T  and B  cell interactions 
required for induction of humoral antibody formation to the second of the two an- 
tigens administered sequentially in a  model of antigenic competition. The descriptive 
term  antigen-induced suppression (AIS) was put forth  to  replace the term antigenic 
competition. A preliminary report of this work is being published3 
Materials and Methods 
Experimental  Protoeol.--The  materials and methods employed in the present work were 
similar to those reported in other studies (8).  3 The individual experiments will be  referred 
to in the text. In general, the various experiments carried out to delineate the characteristics 
of antigenic competition were reduplicated exactly, and evidence for altered cell-to-cell inter- 
action in these experiments was sought indirectly employing theta (0)  antigen assays and 
assessment of lymphoid organ mass, as will be shown below. 
Anlmals.--Female  C57BL/6J  mice,  4 3-5  months  of  age,  were  used  throughout  these 
studies. 
Lymphoid  Cell Suspensions.---Cell suspensions used for these studies were prepared as pre- 
viously described  (8).  Assessment of spleen cell  mass was determined by hemocytometer 
counts of the nucleated cell number in a  fixed volume of suspensions prepared on pools of 
three to four individual spleens. In the text "spleen size" will refer to the cell count, not to 
spleen weight. 
Theta Assays.--Anti-O antiserum was prepared according to  the standard procedure of 
Reff and Allen (9).  The donor strain of thymus cells was CBA. Antiserum was tested for 
specificity by cytotoxic testing against thymus cells of either the AKR or CBA strain. In the 
latter case, no lysis was observed, in contrast with 100%  cell lysis when CBA thymus cells 
were employed as target cells using suitably absorbed, fresh guinea pig complement (10). 
The assays for cytotoxicity were based on the method of Boyse et al.  (11), with the modi- 
fication that for each dilution of antiserum (1:2  to 1:64)  a normal AKR serum control was 
performed. The cytotoxicity with normal serum, which is generally in the range of 15-25%, 
was subtracted from the test values obtained with anti-0 serum at each antiserum dilution. 
The results are recorded as percentage of cell lysis, which is a measure of the proportion 
of 0-positive cells in the spleen cell suspension. Most of the results illustrated in the figures 
were obtained using serum dilutions from 1:2 to 1:64.  In some cases (Figs.  1 and 3) only the 
value obtained at the lowest (1:2)  dilution was recorded for the various groups. Moreover, 
at this dilution, a strictly fiat plateau of eytotoxicity over a range of serial dilutions was not 
obtained in some instances, at which time a  semiplateau was usually seen. In general, lysis 
at a dilution of 1:4 was usually 2-5% less than that observed at the 1:2 dilution, whereas at 
higher dilutions the drop was often much steeper from one dilution to the next. 
The results recorded are based on experiments done in duplicate or triplicate. In turn, 
each experiment was performed using three mice per group. Hence, each point on any given 
figure represents the average value obtained from two or three separate experiments using a 
total of six to nine mice. 
2 Kerbel, R. S., and D.  Eidinger. Antigenic competition: a new hypothesis based on  cell 
interactions in the immune response. Submitted for publication. 
Eidinger, D., and M. Baines. 1971. Further studies on antigenic competition. II. Cellular 
deficit or inhibitory factor: an indirect evaluation of the problem. Can. J. Microbiol. In press. 
4 Obtained from the Jackson Laboratories, Bar Harbor, Maine. R.  S.  KERBEL AND DAVID EIDINGER  1045 
RESULTS 
Raft (12, 13) and Schlesinger (14) have independently devised a simple assay 
system to assess the relative numbers of T cells in any lymphoid population 
based on the fact that such cells carry the 0-antigen, while non-T cells do not. 
The assay was based on the discovery  that the thymus cells of most strains of 
mice share a  common 0-antigen  (0-C3H) against which an isoantiserum may 
be prepared in the AKR strain which lacks this 0-C3H antigen (9). 
We  have  adopted  this  assay  system  to  evaluate  indirectly  the  T-B  cell 
cooperative system, the implication being that striking deviations from normal 
values of the relative number of T  cells in lymphoid tissues, such as the spleen 
of immune animals, could provide a useful index of the likelihood of cell coopera- 
tion involving T  cells. 
The question which was specifically posed at the outset of the present work 
was whether immunization with an initial antigen under various circumstances 
employed in studies  of antigenic competition (8) ~ was  associated with major 
alterations in the proportion of T  cells in a given lymphoid cell population, in 
this case the spleen, and whether such deviations correlated in any way with 
known kinetic and dynamic features of antigenic competition. 
Antigen-Induced  Proliferative Changes in  Spleens  of Mice  Immunized  with 
Different Antigens.--In  previous work, maximum immunosuppression induced 
by immunization with the initial antigen occurred when the second test antigen 
was administered 24  days after immunization. The exact timing of maximum 
immunosuppression differed with the various pairs of antigens (8). 
In an initial experiment, the reduction in the proportion of 0-positive cells 
and the alteration in the lymphoid cell mass in the spleen were examined at 
daily intervals after immunization with keyhole limpet hemocyanin (KLH). 
The data is illustrated in Fig.  1, from which it may be seen that the greatest 
reduction in 0-positivity occurred on the 2nd day after immunization with KLH 
coincident with the greatest increase in spleen cell size. A second preparation of 
KLH exhibited the greatest alteration in  these  parameters 3 days  after  im- 
munization,  and the material  in  both  instances was  maximally immunosup- 
pressive when used as a suppressing antigen at 2 or 3 days respectively. These 
findings are essentially identical to the findings obtained with goose erythrocytes 
(GRBC), in which the greatest reduction in the proportion of 0-positive cells 
in  association with  the  greatest  increase in  spleen  cell size  occurred 3  days 
after  immunization  2,  thus  corresponding  to  the  optimum  time  interval  to 
achieve maximum  immunosuppression  in  a  model  of  antigenic  competition. 
The  reduction  in  the  proportion  of  T  cells  in  association  with  increased 
spleen size was then examined at intervals of 2 or 3 days after immunization 
with  a  variety  of  antigens  previously employed  as  suppressing  antigens  in 1046  MODEL  OE  ANTIGENIC  COMPETITION 
models of antigenic competition. The results are summarized in Fig.  2,  from 
which it may be seen that all the antigens used generated a  reduction in the 
proportion of T  cells after immunization. Antigens administered in appropriate 
dosage, which are potent immunosuppressants in models of antigenic conipe- 
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Fro. 1.  Anti4~  cytotoxic  assays on  spleen cells  from C57  mice  immunized with  1 mg of 
KLH  i.v.  at  various time  intervals before  assay,  O  O;  nucleated  spleen cell  hemocy- 
tometer counts on corresponding days,  •  •.  The  %  lysis results shown are  those ob- 
served at the lowest (1 : 2) antiserum dilution in separate assays done for each group, provided 
they did  not  fall  in  a  prozone.  Results are  average  of  identical  experiments performed  in 
duplicate. 
tition, were also associated with the greatest reduction in the proportion of T 
cells,  and the largest increase in spleen cell size (see legends under figures for 
spleen counts); however, antigens such as polyvinylpyrrolidone (PVP), which 
are weakly suppressive of only a  small number of antigens administered sub- R.  S.  KERBEL  AND  DAVID  EIDINGER  1047 
sequently  and  in  which  the  timing  is  critical  to  achieve  suppression  of  the 
response to unrelated  test antigens,  produced a  minimal reduction in the pro- 
portion of T  cells and an increase in splenic mass (8). 
Effect of Antigen Dose on Capacity  of Antigen to Cause Splenic Enlargement 
and a Reduction  in the Proportion  of O-Positive Cdls.--In previous  studies  of 
antigenic  competition  employing  the  sequential  administration  of  two  non- 
cross-reacting antigens,  GRBC followed by rat  erythrocytes (RRBC), the  im- 
munosuppression  induced  by the  initial  antigen  was  shown  to  increase  to  a 
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FIG. 2. Anti-0 cytotoxic assays on spleen ceils from normal and immune C57 mice: norma 
nonimmune  /k  ~  (120 >(  106); ©  O, 0.1 #g PVP injected  2 days before  (200 X 
106); raN----R, 0.2 cc 20% RRBC injected 3 days before (210 X  106); •  @, 0.2 cc 20% 
GRBC injected 3 days before (343 X  106); •  •,  1 KLH injected 3 days before (280 X 
106). All injections by i.v. route. The numbers above recorded in parentheses refer to average 
hemocytometer counts of nucleated spleen cells from the various groups. Results are average 
of identical experiments performed in duplicate. 
maximum  at dose levels  of 10-20%.  Consequently,  the  effect of dose  on the 
reduction  of the proportion of T  cells  and  the increase in spleen  size was de- 
termined 3 days after immunization  with varying doses of GRBC. 
The results  are  shown in Fig.  3.  It may be seen that  the  reduction  in  the 
proportion of 0-positive cells 3 days after immunization with GRBC occurred 
maximally when a dose of 0.2 cc of 20% GRBC was administered.  In addition, 
increasing the dose of GRBC resulted in progressively larger increases in spleen 
cell size until a maximum was reached at a 20% dose level. Increasing the dose 
to  50%  GRBC  actually  resulted  in  less  marked  changes.  Thus,  the  inverse 
relationships  of increasing spleen cell size with decreasing proportion of 8-posi- 1048  MODEL  0]?  ANTIGENIC  COMPETITION 
tive cells correlated exactly with the dose levels of GRBC  yielding maximum 
immunosuppression  in  a  model of antigenic competition. 
Effect  of Primary  vs.  Secondary  Immune  Responses  to  an  Antigen  on  the 
Capacity of that Antigen to Induce an Alteration in the Proportion  of O-Positive 
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FIG. 3.  Anti-0 cytotoxic assays on spleen  cells from  C57  mice immunized  with varying 
doses of 0.2 cc GRBC suspensions three days before  •  0; spleen cell hemocytometer 
counts on corresponding  groups  O----O. Immunizations by i.v. route. Details of recording 
of results are as for Fig. 1. 
Cells  and  Spleen Enlargement.--Previous  studies  in  several laboratories have 
indicated that a  secondary immune response to an antigen is less effective than 
a  primary  immune  response  (using  an  equivalent  dose)  in  suppressing  the 
immune response to a  sequentially administered non-cross-reacting antigen in 
a  model  of  antigenic  competition  (15-17). R.  S.  KERBEL  AND  DAVID  EIDINGER  1049 
It was decided therefore to assess the ability of a secondary immune response 
against  a  primary  immune  response  to  GRBC  in  altering  the  proportion  of 
0-positive  cells  and  spleen  cell  numbers.  Accordingly,  a  group  of mice  was 
injected  with  0.2  cc of  10%  GRBC  on day 0  and  again  on day 30.  3  days 
later the spleens  were removed,  counted and  assayed,  and  were compared to 
respective controls receiving only a single dose of GRBC 3 days before. As may 
be seen in Fig. 4, the secondary immune response to GRBC was less effective in 
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Fio. 4.  Anti-0 cytotoxic assays on spleen cells from C57 mice immunized with 0.2 cc 10% 
GRBC 3 days before,  •  •  (268 X  106); immunized with  10% GRBC 33 days and 3 
days before, /X  A  (168 X  106); nonimmune control,  O  O  (112 X  106). All immu- 
nizations by i.v. route. Numbers above in parentheses refer to average hemocytometer counts 
of nucleated  spleen cells of the various groups. No difference was obtained between nonim- 
mune mice and mice primed with  10% GRBC 33 days earlier  (not shown above). Results 
are average of identical experiments performed in duplicate. 
decreasing the proportion of 0-positive cells in the spleen 3 days after immuni- 
zation. Moreover, the secondary response was equally less effective in generat- 
ing splenic  enlargement  in comparison to a  primary response  induced by the 
administration  of an equivalent dose of antigen. 
Effect of Inhibiting  the Immune Response to the Initial Antigen in Models of 
Antigenic  Competition  by Different  Means  on  the Capacity  of the Antigen  to 
Induce O-Cell Population  Changes and Spleen Enlargement.--Various  workers, 
including ourselves (18,  19) 3  , have manipulated the model of antigenic compe- 
tition  by  employing  various  immunosuppressive  agents  coincident  with,  or 1050  MODEL  OF  ANTIGENIC  COMPETITION 
soon after, administration  of the initial suppressing antigen. The basic premise 
was  that  specific  alteration  of immune  induction  to  the  initial  antigen,  if  it 
was associated with an abolition of immunosuppression in a model of antigenic 
competition, might provide some insight into the underlying mechanism of the 
phenomenon.  During  the  course  of such studies,  it was shown  by Wust  and 
Hanna  as well  as ourselves  (18) 3 that  actinomycin-D in  suitable  dosage pre- 
30. 
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FIo. 5. Anti-0  cytotoxic  assays on spleen cells from mice immunized with  0.2 cc 10% 
GRBC i.v.  3 days before and given 0.60 mg/kg body weight actinomycin-D  24 hr later, 
•  •  (101)~  106); immunized with GRBC  only 3 days before, H  (306 X  106); 
nonimmune control, •  •  (118 X  106). Numbers in parentheses above refer to average 
hemocytometer  counts  of nucleated  spleen cells of various  groups. Results  are  average of 
identical experiments performed in triplicate. 
vented the suppressing  capacity as well as the induction  of immune response 
to the initial antigen.  Cyclophosphamide was shown to behave similarly when 
administered  a  short  time  after  administration  of  the  initial  suppressing 
antigen  (19).  On the  other hand,  the  observation  that induction  of tolerance 
to the initial antigen employing cyclophosphamide did not inhibit the capacity 
of  antigen  to  suppress  the  immune  response  to  subsequently  administered 
non-cross-reacting antigen  3 was in essential agreement with other observations 
that induction of high dose tolerance is associated with continuing capacity to 
suppress employing models of antigenic competition (20, 21). R.  S.  KERBEL  AND  DAVID  EIDINGER  1051 
In order to assess the correlation between these observations and the present 
proposed  model  to  account  for  antigenic  competition,  several  experimental 
protocols were reduplicated correlating immunosuppression in models of anti- 
genic competition with a  reduction in the proportion of 0-positive cells and a 
cell proliferation in the spleen leading to an increase in its size. 
The data are illustrated  in  Figs.  5-7 and  in Table I.  Fig.  5  illustrates  the 
30- 




~,  lo- 
O_ 
i  i  ; 
2  4  8"  1-6  ~  6-4 
Dilution  of  Anti-O 
FIG. 6.  Anti-0 cytotoxic assays on spleen cells from mice immunized with 0.2  cc  10% 
GRBC i.v. 2 days before and given 100 mg/kg body weight cyclophosphamide 24 hr later, 
O  O  (150)<  106); immunized with GRBC 2 days before only, []  []  (262)<  10s); 
nonimmune control, Aq--A  (147 X  106). Numbers in parentheses above refer to average 
hemocytometer counts of nucleated spleen cells of various groups. Results are average of 
identical experiments performed in triplicate. 
effect of administering 0.60 #g of actinomycin-D/kg body weight  1 day after 
the initial antigen  GRBC, corresponding to the time of 2 days before the ad- 
ministration of RRBC,  on antigen-induced alteration of spleen size and 0-cell 
population  changes.  It  can  be  seen  that  actinomycin-D  both  inhibited  the 
ability of the antigen to cause an increase in spleen cell size and prevented the 
reduction  in  the  proportion  of  0-positive cells,  both  events  occurring  in  as- 
sociation with the  abolition of ilnmunosuppression  by antigenic  competition. 
A  similar  effect  was  observed  with  cyclophosphamide  administered  1  day 
after GRBC injection  (Fig. 6). In contrast, however, when cyclophosphamide 1052  MODEL  OF  ANTIGENIC  COMPETITION 
was used successfully to induce tolerance to the initial antigen  (see Table I), 
in  this  instance  RRBC,  continued  proliferation  subsequent  to  the  admin- 
istration of the tolerogen was  observed such  that the spleen increased in size 
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FIG. 7.  Anti-0 cytotoxic assays on spleen cells from  C57 mice injected with 0.2 cc 200/0 
RRBC i.v. 3 days before, where the mice were immunologically tolerant to RRBC,  O ..... O 
(261 X  106); injected with 0.2 cc 20%  RRBC  3 days before, Jk----A (242 X  106); non- 
immune, normal control,  •--•  (140 >(106).  Numbers in parentheses  above refer to aver- 
age hemocytometer counts of nucleated spleen cells of the different groups. Results are aver- 
age of identical experiments  performed in triplicate. For details of induction and assessment 
of tolerance see Table I. 
immune animals (Fig. 7). Thus, it appears that cell proliferation was persistent 
in such tolerant animals despite the virtual absence of any antibody production. 
Previous  work had  shown  that  RRBC  injected  into  RRBC-tolerant  animals 
retains  its  capacity to  suppress  the  immune  response  to  a  subsequently  ad- 
ministered unrelated antigen, in this case KLH,  equivalent to the suppression R.  S.  KERBEL  AND  DAVID  EIDINGER  1053 
observed in  a  control nontolerant  group  employing RRBC  as  the initial anti- 
gen? 
In summary  (see Table I),  close correlation was  obtained  between antigen- 
induced reductions in 0-positivity in the spleen  with increased spleen size and 
TABLE  I 
Relationships  between Suppression  of the Immune  Response  to  the  First of  Two Sequentially 
Administered Antigens and the Ability of the Antigen to Act as a Suppressing Antigen, 
Increase  Spleen  Size,  and  Decrease the Proportion  of O-Positive Cells, 
2-3 Days after Immunization 
Experimental  Effect of drug  Effect on capacity of  Effect on capacity 
means by which  treatment on  first antigen to  of antigen to 
response to first  competitive  ability  cause increase in  induce changes  in the 
antigen was  of first antigen  spleen size 2-3 days  proportion  of 0-positive 
suppressed  to suppress  postimmunization  cells in spleen 
0.60-0.75 mg of 
act. D/kg ad- 
ministered 
24-48 hr after 
initial antigen 
100 mg/kg cy- 
clophospha- 
mide given 24 





ance using cy- 
clophospha- 
mide* 
Abolished or se-  Abolished: spleen 




Abolished or se-  Abolished: spleen 






Not abolished or  Not abolished or  Not affected: tol- 
impaired: toler-  impaired: toler-  erated antigen 
ated antigen as  ated antigen re-  still causes low- 
efficient as non-  tains capacity to  ered proportion 
tolerated antigen  increase size of  of 0-positive cells 
in manifesting  spleen to same  to same degree as 
competition ef-  degree as antigen  nontolerant anti- 
fects  in nontolerant  gen 
animal 
* Tolerance was induced by the injection of 1 cc of 50% RRBC followed by four consecu- 
tive daily injections of cyclophosphamide in a  dose of  50 mg/kg body weight.  Mice were 
challenged 3 wk later with 0.2 cc of 20% RRBC.  Circulating hemagglutinins were not de- 
tected up to 3 wk after challenge. 
the capacity of the antigen to induce immunosuppression in a model of antigenic 
competition. 
DISCUSSION 
Many  characteristics  of  antigenic competition have  been delineated  in pre- 
vious work  employing sequential administration  of two antigens separated  by 
an  appropriate  time  interval  (8).  The  time  interval  required  for  maximum 1054  MODEL  OF  ANTIGENIC  COMPETITION 
immunosuppression  was  a  critical variable dependent  on the  characteristics 
of the pair of antigens employed in the studies (8), a finding in agreement with 
many others (4, 5). Intervals of 2 or 3 days were the most frequently observed. 
The use of such model systems of antigenic competition has permitted many 
groups of workers to delineate the characteristics of this phenomenon (4,  5, 
15,  22).  Both  thymus-dependent  and  highly  thymus-independent  antigens 
are  capable  of  acting  as  initial  suppressing  antigens,  or  as  test  antigens  in 
models  of  antigenic  competition,  although  thymus-independent  antigens 
appear  much  less  effective as  test  antigens  (8).  3 Immunosuppression  varies 
with the dosage of both the initial and the test antigens. If the dose of the test 
antigen is kept constant the degree of immunosuppression will vary with the 
dose  of  the  initial  antigen,  reaching  a  maximum  with  erythrocyte antigens 
when suspensions of 10-20% cells are administered (8). Induction of a primary 
immune  response to  the  initial  antigen  exerts a  greater  degree of  immuno- 
suppression  of the test antigen than does induction of a  secondary response 
with  an  equivalent dose of the  initial  antigen  (15-17).  Actinomycin-D  and 
cyclophosphamide administered in appropriate dosages after injection of the 
initial antigen prevent the capacity of that  antigen to suppress the immune 
response to the test antigen administered subsequently (18,  19)? On the other 
hand,  induction  of tolerance to the initial  antigen  employing cyclophospha- 
mide, several weeks before the administration of the pair of antigens, does not 
diminish the capacity of the initial antigen to suppress the immune response 
to the test antigen} a  finding similar to the "Liacopoulos phenomenon" (20, 
21). 
The purpose of defining the characteristics of antigenic competition evolved 
from the desire of numerous groups of investigators to attempt to come to an 
understanding  of the  underlying  lesion  in  antigenic  competition.  Thus,  the 
phenomenon could be properly employed in experimental systems as a means 
of focusing on a  specific aspect of induction of the immune response. To this 
end, there has evolved a considerable controversy as to whether the underlying 
mechanism is attributable to actual competition for a cell occurring with limited 
frequency (3,  4),  or  the  development  of  an  inhibitory  environment  due  to 
release of an  inhibitory factor arising  as  a  consequence of immunization to 
the  initial antigen  (5,  22).  Most workers would tend to agree that  antigenic 
competition  is  not  manifested  by  a  competition  for  fixed  macrophages  or 
phagocytic cells (2, 8), while competition for thymus and bone marrow-derived 
immunocompetent cells has  not  received popular  acceptance since  it  would 
necessitate  a  requirement  for  a  multipotent cell  occurring  with limited fre- 
quency. Current studies denoting specific cell receptors of an immunoglobulin 
character on lymphoid cells (23-27) would argue strongly for clonal selection 
and  against  the  possibility  of  existence of  a  multipotent  immunocompetent 
cell. R.  S.  KERBEL  AND  DAVID  ELDINGER  1055 
Recent findings  that  htmloral antibody formation to  certain  antigens  de- 
pend  upon  a  cell  cooperation  between  thymus-  and  bone  marrow-derived 
cells (6,  7)  prompted us to investigate whether antigenic competition was as- 
sociated with a specific environmental alteration which in some way diminished 
the efficiency of cell-to-cell interaction required to generate antibody formation 
to the test antigen.  In this work,  the number of cells carrying the ~-marker 
which  are presumed to be T  cells (12,  14),  as  well as  estimates  of the total 
numbers of cells in maximally stimulated organs,  were chosen initially as two 
indices  representative  of  the  alteration  in  lymphoid  tissues  occurring  as  a 
consequence  of  immunization  to  an  antigen.  It  was  considered  that  such 
studies would provide an indirect evaluation of the efficacy of cell cooperation 
occurring in immune environments to unrelated  test antigens.  For this pur- 
pose, mice were immunized with antigen in a  dosage and form corresponding 
to the experimental protocols employed in previous studies of antigenic compe- 
tition, and the effects of such immune induction were determined employing 
assays of the proportion of ~-containing cells and estimates of lymphoid cells 
in the spleens of immune animals. 
Excellent correlation was obtained between the capacity of an initial antigen 
to suppress  in  a  model of antigenic competition on the  one hand,  with  the 
reduction in the proportion of T  cells and increase in spleen cell mass on the 
other hand. Moreover, the reduction in the proportion of T  cells was inversely 
related to the increase in splenic size. In this way, it was shown that the greatest 
reduction in the proportion of T  cells in association with the greatest enlarge- 
ment of spleen cell mass occurred 3 days after immunization, thus correspond- 
ing to the time at which the antigens, GRBC and KLH, were maximally im- 
munosuppressive  in  antigenic  competition.  Numerous  antigens  caused  a  re- 
duction in  the proportion of T  cells  with  a  concomitant increase  in  splenic 
size. The greater the capacity of an antigen to suppress in a model of antigenic 
competition, the greater the reduction of the proportion of T cells with increase 
in spleen size was  observed. For example,  GRBC  generated a  much greater 
reduction in the proportion of T cells than did PVP, which is much less capable 
of suppressing  the model  of antigenic competition than  the  former antigen. 
The dose of antigen producing a maximal reduction in the proportion of T cells 
corresponded exactly to the dose of antigen maximally suppressive in antigenic 
competition. Secondary immune responses generated a lesser reduction in the 
proportion of T  cells and an increase in spleen size than did primary immune 
responses, in direct agreement with the results of studies on antigenic compe- 
tition.  Actinomycin-D  or  cyclophospha.mide  administered  24  hr  after  the 
initial antigen in  a  model of antigenic competition prevented suppression  of 
the  response to the test antigen,  while similarly preventing the reduction in 
the proportion of T  cells and the increased spleen size observed after immuni- 
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phosphamide-induced tolerance to the initial antigen did not prevent immuno- 
suppression by antigenic competition,  3 nor did it alter the sharp reduction in 
the proportion of T  cells and the increase in spleen cell size. 
Several points are worthy of amplification. It is  evident that  the immune 
response to the initial antigen can be suppressed or inhibited altogether, without 
affecting the capacity of the antigen to retain its competitive ability, provided 
the  antigen can still  induce a  proliferative response in the spleen generating 
splenic enlargement and a reduction in the proportion of T  cells.  Thus, if the 
immune response to the initial antigen is inhibited by cytotoxic drugs such as 
actinomycin-D  or  cyclophosphamide administered  during  the  3  day  period 
employed in  studies  of antigenic  competition,  specific cell proliferation  and 
increase in  spleen size with  overall reduction in  the proportion of T  cells is 
prevented. In these instances, antigenic competition does not occur. However, 
if the response to the initial antigen is nearly totally abolished by the induction 
of tolerance 3 wk previously employing cyclophosphamide, such that the im- 
mune response measured in terms of antibody formation is virtually absent, 
the splenic enlargement and cell proliferation generating a reduced proportion 
of T  cells  is not altered.  Moreover, the tolerogen continues to be effective in 
suppressing a test antigen in antigenic competition. 
In summary, it is evident that specific and massive cell proliferation appears 
to  be  a  necessary prerequisite  for  the  expression  of  antigenic  competition, 
whereas  antibody production  per  se  is  not.  Dukor  and  Dietrich  concluded 
from their recent findings that a  "competitive proliferation" was  responsible 
for the  mechanism  of antigenic competition  (19).  However, there is  no  evi- 
dence that a  competitive proliferation between clones of cells  specific for one 
or two  competing antigens  has  occurred.  Indeed,  if this  were  the  case,  one 
would expect suppression of both responses to occur when both antigens  are 
administered simultaneously, instead of the normal responses which are actually 
observed (5). 
The apparent requirement of a proliferation-induced expansion in spleen cell 
number, the kinetics of which correlate with the kinetics of immunosuppression 
by antigenic competition, as well as with changes in 0-positivity in the spleens 
of immunized mice, provided evidence for the evolution of a model to explain 
the mechanism  of antigenic  competition,  the  essential features of which  are 
shown in diagrammatic fashion in Fig. 8.  It is proposed that the injection of 
the initial  antigen results  in  a  massive proliferation of T  and  B  cells  of the 
specificity corresponding to that antigen, i.e., clonallv restricted cell prolifera- 
tion.  In  this  manner,  specific T  and  B  cells  required  for the  interaction to 
antigen  Y  are  "diluted  out."  The end  result  of this  proliferation-dependent 
process is  to decrease the chance of an interaction between T  and  B  cells  of 
identical specificity, required for the induction of an  immune response to the 
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The  greater  the  proliferative  response  to  the  first  antigen,  the  greater  the 
dilution  effect, hence  the  more likely the  response to the test  antigen  will be 
suppressed. 
Since this  theory,  as proposed,  is dependent  upon  a  requirement  for inter- 
acting T  and B  cells, it follows that suppression of immune respgnses to highly 
thymus-independent  antigens  such  as  PVP  (28) s  would  be  very  difficult  to 
suppress  by antigenic  competition,  since  such  antigens  do  not  appear  to  re- 
quire  the interaction  of T  with B  cells (29).  We have previously reported this 
to  be the  case.  3 Thus,  suppression  of the  anti-PVP  response  by a  competing 
antigen  is dependent  upon  a  critical  (high)  dosage of the first antigen  as well 
as a  critical  time interval, unlike models involving two competing heterologous 
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FIG. 8.  Diagrammatic representation of the underlying  events associated with the mecha- 
nism of antigenic  competition.  Antigen  X: T  cell, e; B cell,  @. Antigen Y: T  cell,  ~; B 
cell, ®. 
erythrocytes.  Alternatively,  one  could  speculate  that  the  suppression  of  the 
PVP response by unrelated antigens may be due to interference with interaction 
between  antigen  and  B  cells  occurring  in  a  hyperplastic  spleen.  Clearly,  it 
should  be  more  difficult  to  interfere  with  interactions  requiring  two  com- 
ponents  than  with  interactions  requiring  three  components,  namely  those 
requiring  contact of antigen with T  and B  cells,  which is the minimal require- 
ment  for induction  of antibody  formation  to  T-dependent  antigens. 
In summary, this simple model presented herewith,  to account for the mech- 
anism  of  antigenic  competition,  consolidates  as  well  as  accounts  for  almost 
all  of  the  characteristics  of this  phenomenon.  In particular,  it  is  compatible 
with  current  clonal  selection  theories  of  immunity  (1).  In  this  regard,  it  is 
5 Kerbel, R. S., and D. Eidinger.  1971. Variable effects of anti-lymphocyte serum on hu- 
moral antibody formation; role of thymus dependency  of antigen.  J. Immunol. In press. 1058  MODEL  OF  ANTIGENIC COMPETITION 
ironic to note that  the  phenomenon  of  antigenic  competition has  for years 
been used as an argument against  clonal-selection or cell-receptor theories of 
immunity (1). Paradoxically, the model proposed is not only compatible with 
such theories, it is dependent upon them. 
Finally,  we should like to  suggest  that  the  term  "antigenic  competition" 
be replaced by a more descriptive phrase such as "antigen-induced suppression". 
The term has the quality of brevity and is conceptually correct, which is not 
true for the time-honored term antigenic competition. 
SUMMARY 
A striking correlation between the capacity of an antigen to nonspecifically 
suppress  humoral  immune  responses  of  subsequently  administered  antigens 
which  are  non-cross-reacting,  i.e.  to  manifest  antigenic  competition  and 
produce  enlargement  of  spleen  size  through  cell  proliferation,  was  found. 
Increase in spleen size was always accompanied by a drop in the normal pro- 
portion of thymus-derived cells to non-thymus-derived cells. 
Various means of altering the immune response to the initial  antigen,  and 
hence, the capacity of that antigen to suppress in a  model of  antigenic  com- 
petition were performed and correlated with changes in spleen size and  in  the 
proportion of 0-positive cells  in the spleen. In all instances, when  the  experi- 
mental condition reduced or abolished antigenic competition, the  increase  in 
spleen  size  and  reduction in  the  proportion  of 0-positive cells in  the  spleen 
was  reduced or abolished.  Furthermore, under conditions in which  the  sup- 
pressive capacity of the initial antigen was unaltered,  the increase  in  spleen 
size and reduction in 0-proportion occurred normally. Finally, the  better  the 
suppression in  a  model of antigenic competition, the greater the  increase  in 
spleen size and reduction in the proportion of 0-positive cells. 
On the basis  of these observations, it appears that there is  a  relationship 
between spleen enlargement through clonally restricted cell proliferation  and 
the expression of antigenic competition; one cannot have the latter without the 
former. It is  postulated  that  the  immunological lesion associated  with  anti- 
genic competition resides at the level of interference with cell interaction  be- 
tween  thymus-derived  antigen-reactive  cells  and  marrow-derived  antibody- 
forming cells.  This occurs as a  result of a  relative "diluting out"  of  cells  of 
both populations carrying antigenic specificity differing from the  one(s)  which 
induced the dilution effect in the first place. The net effect of this is to decrease 
the chance of a  "hit" or interaction between a marrow-derived  and  thymus- 
derived cell of the same specificities. 
This mechanism, which is compatible with theories of clonal  selection,  and 
which in fact is dependent upon them, supports the view that the  term  "anti- 
genic competition"  is  a  misnomer;  there  is  no  competition by  the  antigens 
for anything. The term "antigen-induced suppression" is suggested as  a  more 
suitable alternative. R.  S.  KERBEL AND  DAVID EIDINGER  1059 
Note Added in Proof.--It has recently come to our attention that Talmage et al.  (1971. 
Cell interaction in antibody synthesis.  Adva•.  Immunol.  12:1271.)  have  suggested that the 
data initially interpreted in favor of the role of an inhibitory factor in antigenic competition 
(ref. 5 of bibliography), may necessitate  reinterpretation based on the observations of re- 
quirement for T and B cell interaction in humoral antibody formation.  We would concur with 
the implication that differences in cell cooperation could account for their data. 
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